Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 16, 2016 - Issue 1
Submit an article Journal homepage
424
Views
6
CrossRef citations to date
0
Altmetric
Reviews

The use of progestogen-only pill in migraine patients

Gianni AllaisDepartment of Surgical Sciences, Women’s Headache Center, University of Turin, Turin, ItalyCorrespondence[email protected]
,
Giulia ChiarleDepartment of Surgical Sciences, Women’s Headache Center, University of Turin, Turin, Italy
,
Fabiola BergandiDepartment of Surgical Sciences, Women’s Headache Center, University of Turin, Turin, Italy
&
Chiara BenedettoDepartment of Surgical Sciences, Women’s Headache Center, University of Turin, Turin, Italy
Pages 71-82 | Published online: 23 Dec 2015

References

  • Papers of special note have been highlighted as: • Of interest•• Of considerable interest
  • Headache Classification Committee of the International Headache Society (IHS). The international Headache Classification. 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.

•• A fundamental guideline for classifying headache.

  • Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–349.
  • Buse DC, Loder EW, Gorman JA, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American migraine prevalence and prevention Headache. 2013;53:1278–1299.
  • Silberstein SD, Merriam GR. Sex hormones and headache. J Pain Symptom Manage. 1993;8:243–259.
  • Chai NC, Peterlin BL, Calhoun AH. Migraine and Estrogen. Curr Opin Neurol. 2014;27(3):315–324.
  • MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004;3(6):354–361.
  • Nappi RE, Sances G, Brundu B, et al. Estradiol supplementation modulates neuroendocrine respond to M-Chlorophenylpiperazine in menstrual status migrainous triggered by oral contraceptive-free interval. Human Reproduction. 2005;20(12):3423–3428.
  • Karli N, Baykan B, Ertas M, et al. Turkish Headache Prevalence Study Group. Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women. J Headache Pain. 2012;13(7):557–565.
  • Alkema L, Kantorova V, Menozzi C, et al. National regional,and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet. 2013;381:1642–1652.
  • Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. Natl Health Stat Report. 2012;18(60):1–2.
  • Skouby SO. Contraceptive use and behaviour in 21st century: a comprehensive study across five Europe countries. Eur J Contracept Reprod Health Care. 2010;15(S2):S42–S53.
  • Maguire K, Westhoff C. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011;205:S4–S8.
  • Morotti M, Remorgida V, Venturini PL, et al. Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptom caused by endometriosis in patient with migraine without aura. Eur J Obstet Gynecol. 2014;179:63–68.

•• An important analysis about two main disease that affect childbearing women and a comparison of two contraceptive methods used in these women.

  • McCann MF, Potter LS. Progestin-only oral contraception: a Comprehensive review. Contraception. 1994;50:S1–S195.
  • Morotti M, Remorgida V, Venturini PL, et al. Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study. Eur J Obstet Gynecol. 2014;183:178–182.

• A retrospective study comparing two contraceptive methods used in women suffering of migraine.

  • Nappi RE, Sances G, Allais G, et al. Effects of estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study. Contraception. 2011;83(3):223–228.

•• A prospective diary-based pilot study where women with migraine with aura, who can assume combined oral contraceptive, test the progestogen only contraception and its effects on migraine.

  • Granella F, Sances G, Zanferrari C, et al. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache. 1993;33:385–389.
  • Aegidius K, Zwart JA, Hagen K, et al. Oral contraceptive and increased headache prevalence: the Head-Hunt Study. Neurology. 2006;66(3):349–353.
  • Cupini LM, Matteis M, Troisi E, et al. Sex hormone related events in migrainous female. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995;14:140–144.
  • Massiou H, MacGregor EA. Evolution and treatment of migraine with oral contraceptive. Cephalalgia. 2000;20(3):170–174.
  • Loder EW, Buse DC, Golub JR. Headache as a side effect of combination estrogen-progestinoral contraceptive: a systemic review. Am J Obstet Gynecol. 2005;193(3 Pt 1):636–649.
  • Sulak PJ, Scow RD, Preece C, et al. Hormone withdrawal symptoms in contraceptive users. Obstet Gynecol. 2000;95:261–266.
  • MacGregor EA. Contraception and headache. Headache. 2013;53(2):247–276.

•• The review examines the evidence about migraine and contraception, especially concerning migraine attack, cardiovascular and thromboembolic risk.

  • Sulak PJ, Kuehl TJ, Ortiz M, et al. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduced hormone withdrawal symptoms. Am J Obstet Gynaecol. 2002;186(6):1142–1149.
  • Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol. 2003;101:653–661.
  • Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003;68:89–96.
  • Nappi RE, Terreno E, Sancez G, et al. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception. 2013;88:369–375.
  • Klipping C, Duijkers I, Trummer D, et al. Suppression of ovary activity with drospirenone-containing oral contraceptive in 24/4 regimen. Contraception. 2008;78(1):16–25.
  • Sullivan H, Furniss H, Spona J, et al. Effect of 21-day and 24-day oral contraceptive regimen containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovary activity. Fertil Steril. 1999;72(1):115–120.
  • World Health Organisation. Medical Eligibility Criteria for contraceptive use, 5th edn. A WHO Family Planning Cornerstone. 2015; Geneve, Switzerland: WHO.

•• WHO’s evidence-based guideline on contraceptive use. The paper reviews the use of hormonal contraceptive methods in women with different characteristics and diseases.

•• CDC’s evidence-based guideline on contraceptive use. The paper reviews the use of hormonal contraceptive methods in women with different characteristics and diseases.

•• Royal College’s evidence-based guideline on contraceptive use. The paper reviews the use of hormonal contraceptive methods in women with different characteristics and diseases.

  • Baillargeon JP, McClish DK, Essah PA, et al. Association between the current use of low dose oral contraceptive and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab. 2005;90(7):3863–3870.
  • Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptive: a meta-analysis. Jama. 2000;5; 284(1):72–78.
  • Chan WS, Ray J, Wai EK, et al. Risk of stroke in women exposed to low dose oral contraceptive: a critical evaluation of the evidence. Arch Intern Med. 2004;12;164(7):741–747.
  • Bousser M-G, Conard J, Kittner B, et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia. 2000;20:155–156.
  • Allais G, Gabellari IC, De Lorenzo C, et al. Oral contraceptive in migraine. Expert Rev Neurother. 2009;9(3):381–393.
  • Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. Bmj. 2005;330(7482):63.
  • Donaghy M, Chang CL, Poulter N. European collaboration of the world health organization, collaborative study of cardiovascular disease and steroid hormone contraception. duration, frequency, recenty and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73(6):747–750.
  • Carolei A, Marini C, De Matteis G. Hystory of migraine and risk of cerebral ischemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet. 1996;347(9014):1503–1506.
  • MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and the risk of ischemic stroke. The stroke prevention in young women study. Stroke. 2007;38(9):2438–2445.
  • Mantha S, Karp R, Raghavan V, et al. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. Bmj. 2012;345:e4944.
  • Merki-Feld GS, Imthurn B, Seifert B, et al. Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine. Eur J Contracept Reprod Health Care. 2013;18(5):394–400.

* Evaluation of the desogestrel quality of life impact in women with migraine.

  • Merki- Feld GS, Imthurn B, Langner R, et al. Headache frequency and intensity in female migraineurs using desogestrel-only contraception: a retrospective pilot diary stud. Cephalalgia. 2013;33(5):340–346.

• A restrospective study that analyses the effect of desogestrel oral contraception on migraine with aura and without aura.

  • Chakhtoura Z, Canonico M, Gompel A, et al. Progestogen-only contraceptives and the risk of stroke: a meta-analisys. Stroke. 2009;40(4):1059–1062.
  • Martin V, Wernke S, Mandell K, et al. Defining the relationship between ovarian hormones and migraine headache. Headache. 2005;45:1190–1201.
  • Somerville BW, Carey HM. The use of continuous progestogen contraception in the treatment of migraine. Med J Aust. 1970;1(21):1043–1045.
  • Singh I, Singh D. Progesterone in the treatment of migraine. Lancet. 1947;1:745–747.
  • Bradley W, Hudgson P, Foster J, et al. Double- blind controlled trial of a micronized preparation of flumedroxone (Demigran) in prophylaxis of migraine. Bmj. 1968;3:531–533.
  • Davies P, Fursdon-Davies C, Rees MC. Progestogens for menstrual migraine. J Br Menopause Soc. 2003;9(3):134.
  • Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22(4):355–365.
  • Somerville BW. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology. 1972;25(3):245–250.
  • Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part I. Headache. 2006;46(1):3–23.
  • Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part II. Headache. 2006;46(3):365–386.
  • Jayaraman A, Pike CJ. Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in coltured neurones. J Neuroendocrinol. 2009;21(1):77–81.
  • Eikermann-Hearter K, Kudo C, Moskowitz MA. Cortical spreading depression and estrogen. Headache. 2007;47(Suppl 2):S79–85.
  • Endrikat J, Gerlinger C, Richard S, et al. Ovulation inhibition doses of progestins: a systematic review of the available review and of marketed preparations worldwide. Contraception. 2011;84(6):549–557.
  • Nappi RE, Merki-Feld GS, Terreno E, et al. Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?. J Headache and Pain. 2013;14:66–71.
  • Ferrero S, Pretta S, Bertoldi S, et al. Increased frequency of migraine among women with endometriosis. Hum Reprod. 2004;19(12):2927–2932.
  • Tietjen GE, Conway A, Utley C, et al. Migraine is associated with menorrhagia and endometriosis. Headache. 2006;46(3):422–428.
  • Tietjen GE, Bushnell CD, Herial NA, et al. Endometriosis is associated with prevalence of comorbid conditions in migraine. Headache. 2007;47(7):1069–1078.
  • Nyholt DR, Gillespie NG, Merikangas KR, et al. Common genetic influences underlie comorbidity of migraine and endometriosis. Genet Epidemiol. 2009;33(2):105–113.
  • Karp BI, Sinaii N, Nieman LK, et al. Migraine in women with chronic pelvic pain with and without endometriosis. Fertil Steril. 2011;95(3):895–899.
  • Yang MH, Wang PH, Wang SJ, et al. Women with endometriosis are more likely to suffer from migraines: a papulation- based study. PLoS One. 2012;7(3):e33941.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.